Reducing Structural Inequities in Heart Failure Management: An Approach to Improve the Quality of Heart Failure Care on the General Medicine Service: Longitudinal Equity Action Plan (LEAP)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03942978 |
|
Recruitment Status : Unknown
Verified May 2019 by Robert Boxer, MD, Brigham and Women's Hospital.
Recruitment status was: Not yet recruiting
First Posted : May 8, 2019
Last Update Posted : May 8, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Heart Failure | Other: Longitudinal Equity Action Plan | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 100 participants |
| Allocation: | Randomized |
| Intervention Model: | Sequential Assignment |
| Intervention Model Description: | Stepped Wedge Randomized Control Trial |
| Masking: | Single (Participant) |
| Primary Purpose: | Supportive Care |
| Official Title: | Reducing Structural Inequities in Heart Failure Management: An Approach to Improve the Quality of Heart Failure Care on the General Medicine Service: Longitudinal Equity Action Plan (LEAP) |
| Estimated Study Start Date : | May 31, 2019 |
| Estimated Primary Completion Date : | May 31, 2020 |
| Estimated Study Completion Date : | August 31, 2020 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Longitudinal Equity Action Plan (LEAP)
Heart failure patients admitted with a principal diagnosis of heart failure to general medicine service and admitted to a general medicine pod that is randomized to the intervention arm.
|
Other: Longitudinal Equity Action Plan
Patients admitted to general medicine pod randomized to intervention will receive a Longitudinal Equity Action Plan (LEAP), which will include a program manager to ensure they are on appropriate medical therapy, that cardiology is consulted when appropriate, that patient is set up with appropriate follow-up appointment with cardiology, that transportation is set up for follow-up visits, and a post-discharge follow up call to remind patients of the appointment and identify any post-discharge issues. This is in addition to standard of care, and there will not be any drug or device interventions. |
|
No Intervention: Standard Care
Heart Failure patients admitted to a general medicine pod at our institution, which is not randomized to intervention arm. Patients will be treated for their heart failure as per standard of care while admitted to the hospital.
|
- Cardiology post-discharge follow-up within 14 days [ Time Frame: 14 days ]Rates of patients that complete post-discharge follow up appropriate with a cardiologist within 14 days of discharge
- Seven-day Heart Failure Readmission [ Time Frame: 7 days ]Rate of 7-day HF readmissions
- 30-day Heart Failure Readmission [ Time Frame: 30 days ]Rate of 30-day HF Readmissions
- Cardiology post-discharge follow-up within 30 days [ Time Frame: 30 days ]Rates of patients that complete post-discharge follow up appropriate with a cardiologist
- Cardiology Consultation [ Time Frame: Within admission ]Rates of cardiology consultation
- Transportation Support [ Time Frame: Within 14 days of discharge ]Rates of post-discharge follow up visit Transportation Support
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- All patients admitted to the general medicine service at our hospital with a principal diagnosis of heart failure
Exclusion Criteria:
- Patients less than 18 years of age
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03942978
| Contact: Lauren Eberly, MD, MPH | 5054592927 | leberly89@gmail.com | |
| Contact: Evan Shannon, MD, MPH | eshannon2@bwh.harvard.edu |
Other Publications:
| Responsible Party: | Robert Boxer, MD, Principal Investigator, Brigham and Women's Hospital |
| ClinicalTrials.gov Identifier: | NCT03942978 |
| Other Study ID Numbers: |
2019P000951 |
| First Posted: | May 8, 2019 Key Record Dates |
| Last Update Posted: | May 8, 2019 |
| Last Verified: | May 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Heart Failure Heart Diseases Cardiovascular Diseases |

